AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
NCT04368182
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
Autologous C-TCR055
Sponsor
Zhejiang University